NCT03622450View on ClinicalTrials.gov

The Effect of Colistin Inhalation on Ventilator Associated Pneumonia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 2, 2016

Primary Completion Date

January 6, 2018

Study Completion Date

January 10, 2018

Conditions
Ventilator Associated Pneumonia
Interventions
DRUG

Colistin

Polymyxins are bactericidal drugs that bind to lipopolysaccharides (LPS) and phospholipids in the outer cell membrane of gram-negative bacteria.

DRUG

Carbapenem + Aminoglycoside/ Quinolone

Dual antipseudomonal given as IV for ventilator associated pneumonia for patients with Multi-drug resistant bacteria risk factors

All Listed Sponsors
collaborator

Ain Shams University

OTHER

lead

Nourhan Hassan Osama Thuraya Mohamed

OTHER

NCT03622450 - The Effect of Colistin Inhalation on Ventilator Associated Pneumonia | Biotech Hunter | Biotech Hunter